USP7 and acute lymphoblastic leukemia: Notably, USP7 inhibitor and DXM or prednisone showed various synergistic effects in inhibiting T-ALL growth, ranging from mild to strong, in seven of the eight primary T-ALL patient samples tested (Fig. 5, C and D, and figs.